18 months later, first sickle cell patient treated with CRISPR is still pain free

Victoria Gray. Credit: Meredith Rizzo/NPR
Victoria Gray. Credit: Meredith Rizzo/NPR
[35-year-old Victoria] Gray is the first person in the United States to be successfully treated for a genetic disorder, [sickle cell disease,] with the help of CRISPR, a revolutionary gene-editing technique that makes it much easier to make very precise changes in DNA.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.
[S]he underwent the landmark treatment on July 2, 2019.

Read the original post

Related article:  Why are COVID cases declining dramatically in India?
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend